PHK
CABA icon

Point72 Hong Kong’s Cabaletta Bio CABA Stock Holding History

Point72 Hong Kong’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-452
Closed -$5K – 1933
2021
Q3 		$5K Hold
452
– – ﹤0.01% 1839
2021
Q2 		$4K Buy
+452
New +$4.44K ﹤0.01% 1804
2020
Q1 		– Sell
-5,253
Closed -$73K – 986
2019
Q4 		$73K Buy
+5,253
New +$62.2K 0.02% 601

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Point72 Hong Kong's CABA Position: Q4 2021 in Review

Point72 Hong Kong sold out of Cabaletta Bio (CABA) in Q4 2021, closing a stake of 452 shares — an estimated $5K sold.

Point72 Hong Kong first reported a position in CABA in Q4 2019 and held it in 3 quarters. The position peaked at $73K in Q4 2019. 66 funds tracked by Wall St. Rank hold CABA as of Q4 2021.

  • Point72 Hong Kong reported no remaining Cabaletta Bio position as of Q4 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 452 Cabaletta Bio shares in Q4 2021, an estimated $5K.
  • Point72 Hong Kong first reported a position in Cabaletta Bio in Q4 2019 and held it in 3 quarters.
  • Point72 Hong Kong's Cabaletta Bio position peaked at $73K in Q4 2019.
  • 66 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.